![](https://bloximages.newyork1.vip.townnews.com/esubulletin.com/content/tncms/assets/v3/editorial/6/83/6836b950-62bb-5ec2-b81a-921f7001429b/669776209c995.image.jpg?crop=1763%2C926%2C0%2C124&resize=1200%2C630&order=crop%2Cresize)
Innoblative Announces Successful First-in-Human Use of its Novel Electrosurgical Device for Breast Cancer Treatment
The company's SIRA® RFA Electrosurgical Device designed specifically for patients undergoing breast-conserving surgery (BCS) Breast cancer is the second most common cancer worldwide with over 2.3M new cases each year1 CHICAGO, July 16, 2024 / …